Actively Recruiting
Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography
Led by Matias Vested · Updated on 2025-08-26
120
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n. tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to return to TOF 90%) from neuromuscular block than EMG.
CONDITIONS
Official Title
Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 6 months - 2 years of age
- Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium
- American Society of Anesthesiologists (ASA) physical status classification I to III
You will not qualify if you...
- Known allergy to rocuronium
- Neuromuscular disease that may interfere with neuromuscular data
- Indication for rapid sequence induction
- Prone position
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rigshospitalet
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
M
Matias Vested
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here